The top-loading MESA Spinal Systems feature Zero-Torque Technology®, applying zero torsional loads, or twisting forces, to the spine when locking the screw. Offering a variety of screw types, coupled with revolutionary instrumentation, the systems are uniquely designed to address the most difficult correction maneuvers, while providing the surgeon the ability to one-step lock.
The SERENGETI Minimally Invasive Retractor Systems feature a flexible polymer Retractor, which provides direct visualization and access to the screw heads to allow for simplified rod insertion. The Retractor is inserted with the screw, allowing for one-step, percutaneous placement of the implants.
“The innovative MESA and SERENGETI systems allow surgeons increased flexibility in their intraoperative decision-making, meeting a wide range of current unmet needs in spinal surgeries. The availability of new technologies for surgeons presents significant short and long term advantages to Italian patients,” said Stefano Boriani, MD, Director, Department of Oncologic and Degenerative Spine Surgery, Rizzoli Institute.
Spine leaders from across the country gathered at the Historical Rizzoli Institute to talk about the latest research in complex spine surgeries and review cases of patients treated with K2M products.
The Italian launch marks the latest in a series of important international accomplishments for K2M. Recent milestones include the European expansion of the company’s breakthrough Rail 4D™ Technology in Denmark, Germany, Holland, the United Kingdom, Switzerland, Spain, Sweden, and Ireland, as well as the introduction of its minimally invasive portfolio in Germany and the broader D-A-CH market.
“The Italian launch of MESA and SERENGETI marks another important milestone in K2M’s mission to be the global spine market leader,” stated Eric Major, K2M’s President and CEO. “We look forward to bringing K2M’s full portfolio of breakthrough products to Italy, as it is critical to our commitment to patient care around the world.”
# # #
K2M, Inc. is the largest privately held spinal device company in the world focused on the research, development, and commercialization of innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a global leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s product development pipeline includes: spinal stabilization systems, minimally invasive systems, biologics, and other advancing technologies, such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
Find K2M on Facebook: https://www.facebook.com/
Follow K2M on Twitter: http://twitter.com/
Zeno Group on behalf of K2M, Inc.
Marcie Kohenak, 202-965-7811